On Monday, Molina Healthcare got a positive adjustment to its Relative Strength (RS) Rating, from 70 to 78.
Can You Really Time The Stock Market?
IBD's proprietary RS Rating measures technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
History shows that the market's biggest winners typically have an 80 or higher RS Rating as they launch their biggest climbs. See if Molina Healthcare can continue to show renewed price strength and hit that benchmark.
Molina Healthcare is building a cup with handle with a 359.97 entry. See if the stock can clear the breakout price in heavy volume.
Molina Healthcare reported 6% EPS growth in its most recent report. Sales rose 12%.
The company holds the No. 1 rank among its peers in the Medical-Managed Care industry group. Cigna Group and Alignment Healthcare are also among the group's highest-rated stocks.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
